UBS Group
HLTH

UBS Group’s Cue Health Inc. Common Stock HLTH Stock Holding History

UBS Group’s Portfolio HLTH Stock Details HLTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-70,857
Closed -$13.4K – 10358
2024
Q1 		$13.4K Buy
70,857
+70,347
+13,794% +$16K ﹤0.01% 7105
2023
Q4 		$83 Sell
510
-8,652
-94% -$2.87K ﹤0.01% 8948
2023
Q3 		$4.05K Buy
9,162
+39
+0.4% +$18 ﹤0.01% 7482
2023
Q2 		$3.37K Sell
9,123
-31,822
-78% -$27.2K ﹤0.01% 7639
2023
Q1 		$74.5K Buy
40,945
+6,646
+19% +$14.4K ﹤0.01% 6141
2022
Q4 		$71K Buy
34,299
+33,947
+9,644% +$107K ﹤0.01% 6434
2022
Q3 		$1K Sell
352
-2,503
-88% -$8.87K ﹤0.01% 10115
2022
Q2 		$9K Sell
2,855
-35
-1% -$190 ﹤0.01% 8203
2022
Q1 		$19K Sell
2,890
-1,811
-39% -$16.4K ﹤0.01% 7536
2021
Q4 		$63K Buy
4,701
+2,094
+80% +$23K ﹤0.01% 6713
2021
Q3 		$31K Buy
+2,607
New +$41.1K ﹤0.01% 6726

Other funds holding HLTH

TC
Tarsadia Capital New York $5.64M AUM 15.7% 1-Year Est. Return
OC
Oakmont Corp Los Angeles, California $526M AUM 7.52% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
OPTFSNA
Old Point Trust & Financial Services N A Newport News, Virginia $311M AUM 24.14% 1-Year Est. Return
FFA
Frazier Financial Advisors Columbus, Ohio $181M AUM 11.16% 1-Year Est. Return
RFA
Register Financial Advisors Atlanta, Georgia $326M AUM 48.38% 1-Year Est. Return

UBS Group's HLTH Position: Q2 2024 in Review

UBS Group sold out of Cue Health Inc. Common Stock (HLTH) in Q2 2024, closing a stake of 70,857 shares — an estimated $13.4K sold.

UBS Group first reported a position in HLTH in Q3 2021 and held it in 11 quarters. The position peaked at $74.5K in Q1 2023. 9 funds tracked by Wall St. Rank hold HLTH as of Q2 2024.

  • UBS Group reported no remaining Cue Health Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • UBS Group sold 70,857 Cue Health Inc. Common Stock shares in Q2 2024, an estimated $13.4K.
  • UBS Group first reported a position in Cue Health Inc. Common Stock in Q3 2021 and held it in 11 quarters.
  • UBS Group's Cue Health Inc. Common Stock position peaked at $74.5K in Q1 2023.
  • 9 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q2 2024.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.